Mark S. Sulkowski, Juhi S. Moon, Kenneth E. Sherman, Giuseppe Morelli, Jama M. Darling, Andrew J. Muir, Mandana Khalili, Dawn A. Fishbein, Federico Hinestrosa, Mitchell L. Shiffman, Adrian Di Bisceglie, K. Rajender Reddy, Brian Pearlman, Anna S. Lok, Michael W. Fried, Paul W. Stewart, Joy Peter, Summer Wadsworth, Scott Kixmiller, Anquenette Sloan, Monika Vainorius, Patrick M. Horne, Larry Michael, Meichen Dong, Donna M. Evon, Jodi B. Segal, David R. Nelson, the PRIORITIZE Study Team – 12 July 2021

DESCRIPTION There is currently an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.

Neeral L. Shah, Jennifer B. Miller, Richard S. Kalman, Sonal Kumar – 11 July 2021

Michel Bazinet, Mark Anderson, Victor Pântea, Gheorghe Placinta, Iurie Moscalu, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Liviu Iarovoi, Valentina Smesnoi, Tatina Musteata, Alina Jucov, Ulf Dittmer, Jeff Gersch, Vera Holzmayer, Mary Kuhns, Gavin Cloherty, Andrew Vaillant – 9 July 2021 – Therapy with nucleic acid polymers (NAPs), tenofovir disoproxil fumarate (TDF), and pegylated interferon (pegIFN) achieve high rates of HBsAg loss/seroconversion and functional cure in chronic hepatitis B virus (HBV) infection.

Mercedes Iñarrairaegui, Bruno Sangro – 9 July 2021

Jun‐Wei Zhang, Xu Yang, Hui‐Ru Ding, Lei Zhang, Yi‐Yao Xu, Xin‐Ting Sang, Hai‐Tao Zhao, Wei‐Guang Zhang, Xin Lu – 8 July 2021

8 July 2021

8 July 2021

8 July 2021

8 July 2021